FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:1178-1179 October 16, 1997 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

By Stephen S. Hall. 544 pp. New York, Henry Holt, 1997. $30. ISBN 0-8050-3796-9.

About 25 years ago, an irreverent wag used "lymphodrek" to refer to the mysterious factors released by cultured lymphocytes or macrophages that could activate, attract, or inhibit other mononuclear leukocytes. These enigmatic phenomena seemed to depend largely on ingenious experimental conditions that outsiders found incomprehensible. Moreover, no sooner did one laboratory describe an activity — invariably with an acronym — than another reported a different acronym with similar effects. Who could have predicted that this Babel would yield not only numerous potent lymphokines but also molecules with the power to incite guile, greed, and pitiless malevolence in researchers?

Stephen Hall's . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.